INCLUSION CRITERIA:
Patients and volunteers of any sex, race or ethnicity will be recruited.
CONTROLS:
No psychiatric or severe chronic medical illness at the time of the study, and by history. This includes the absence of substance abuse histories, learning disabilities and all DSM IV disorders. Investigators will evaluate histories and medical conditions that are judged not to interfere with the study.
No use of psychotropic substances in the last 3 months.
There is no upper age limit. The lower age limit is 18 years.
PATIENTS:
Schizophrenia, any subtype or schizo-affective disorder according to DSM IV .
Bipolar Disorder with Psychotic Features according to DSM IV.
Menstrually-Related Mood Disorder.
Mild to moderate Parkinson's Disease (Hoehn and Yahr Stage 1-3).
William's Syndrome (partial or full).
Patients with Multiple Sclerosis.
EXCLUSION CRITERIA:
CONTROLS AND PATIENTS:
Impaired hearing.
Pregnancy.
Head trauma with loss of consciousness in the last year, or any evidence of functional impairment due to and persisting after head trauma.
Patients or healthy volunteers with known risk from exposure to high magnetic fields (e.g. patients with pace makers) and those who have metallic implants (e.g. braces) in the head region (likely to create artifact on the MRI scans) will be excluded from participating in the fMRI studies.
PATIENTS:
Coexistence of another major mental illness at the time of the study.
Criteria for substance abuse met in the last 6 months.
Criteria for substance dependence met in the last year. The duration of the dependency must be less than 3 years and not judged to have produced long-term brain changes.
Major concurrent medical illness likely to interfere with acquisition of the task.
Concomitant medications which could interfere with performance on the task.
Presence of dyskinetic movements of the face and tongue (likely to interfere with eyeblink measures), or of gross involuntary movements of the whole body (likely to interfere with positioning in the MRI scanner).
Pregnant or lactating woemn will be excluded from studies.
All patients smoking or drinking coffee will be asked to refrain 4 hours prior to the study.